Collegium Pharmaceutical's Series C Round

Collegium Pharmaceutical raised a round of funding on March 10, 2015.

Collegium Pharmaceutical is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chron…

Articles about Collegium Pharmaceutical's Series C Round: